No Data
No Data
Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm With SOD2 MRNA Delivered by SemaPhore Nanoparticles
Express News | Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm With Sod2 Mrna Delivered by Semaphore Nanoparticles
Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Express News | Altamira Therapeutics Highlights Review Article Published On Use Of Betahistine In Vertigo Management
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Express News | Altamira Therapeutics Ltd - Merged Entity Will Be Called Altamira Therapeutics AG and Continue to Serve as Core Operating Subsidiary of Company
No Data